Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick C Streich

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature|August 12, 2016
Capturing a substrate in an activated RING E3/E2-SUMO complexFrederick C Streich, Christopher D Lima
Annual Review of Biophysics|April 30, 2014
Structural and functional insights to ubiquitin-like protein conjugationFrederick C Streich, Christopher D Lima
Sub-Cellular Biochemistry|January 12, 2011
Activation of ubiquitin and ubiquitin-like proteinsFrederick C Streich, Arthur L Haas
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2018
Strategies to Trap Enzyme-Substrate Complexes that Mimic Michaelis Intermediates During E3-Mediated Ubiquitin-Like Protein LigationFrederick C Streich, Christopher D Lima
The Journal of Biological Chemistry|February 15, 2013
Tripartite motif ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanismFrederick C Streich, Virginia P Ronchi, J Patrick Connick, et al.
The Journal of Biological Chemistry|October 25, 2014
Convergent evolution in the assembly of polyubiquitin degradation signals by the Shigella flexneri IpaH9.8 ligaseDaniel J Edwards, Frederick C Streich, Virginia P Ronchi, et al.
The Journal of Biological Chemistry|February 21, 2020
Structural basis of specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015Kevin B Dagbay, Erin Treece, Frederick C Streich, et al.
Science Translational Medicine|March 28, 2020
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscapeConstance J Martin, Abhishek Datta, Christopher Littlefield, et al.
Science Signaling|July 9, 2024
An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosisJustin W Jackson, Frederick C Streich, Ajai Pal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature|August 12, 2016
Capturing a substrate in an activated RING E3/E2-SUMO complexFrederick C Streich, Christopher D Lima
Annual Review of Biophysics|April 30, 2014
Structural and functional insights to ubiquitin-like protein conjugationFrederick C Streich, Christopher D Lima
Sub-Cellular Biochemistry|January 12, 2011
Activation of ubiquitin and ubiquitin-like proteinsFrederick C Streich, Arthur L Haas
Methods in Molecular Biology (Clifton, N.J.)|September 23, 2018
Strategies to Trap Enzyme-Substrate Complexes that Mimic Michaelis Intermediates During E3-Mediated Ubiquitin-Like Protein LigationFrederick C Streich, Christopher D Lima
The Journal of Biological Chemistry|February 15, 2013
Tripartite motif ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanismFrederick C Streich, Virginia P Ronchi, J Patrick Connick, et al.
The Journal of Biological Chemistry|October 25, 2014
Convergent evolution in the assembly of polyubiquitin degradation signals by the Shigella flexneri IpaH9.8 ligaseDaniel J Edwards, Frederick C Streich, Virginia P Ronchi, et al.
The Journal of Biological Chemistry|February 21, 2020
Structural basis of specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015Kevin B Dagbay, Erin Treece, Frederick C Streich, et al.
Science Translational Medicine|March 28, 2020
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscapeConstance J Martin, Abhishek Datta, Christopher Littlefield, et al.
Science Signaling|July 9, 2024
An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosisJustin W Jackson, Frederick C Streich, Ajai Pal, et al.
Pageof 1